Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Urology Case Reports
|
April 6, 2017
A Case Report of Priapism With Unusual Presentation and Clinical Course
Wenjie Zhong, Hamesh Jina, Prem Rathore, et al.
Patient Education and Counseling
|
February 27, 2019
Robot or radiation? A qualitative study of the decision support needs of men with localised prostate cancer choosing between robotic prostatectomy and radiotherapy treatment
Allan 'Ben' Smith, Orlando Rincones, Mark Sidhom, et al.
BMJ Open
|
November 6, 2017
Prostatectomy versus radiotherapy for early-stage prostate cancer (PREPaRE) study: protocol for a mixed-methods study of treatment decision-making in men with localised prostate cancer
Allan Ben Smith, Pascal Mancuso, Mark Sidhom, et al.
Urologic Oncology
|
June 12, 2021
Low conflict and high satisfaction: Decisional outcomes after attending a combined clinic to choose between robotic prostatectomy and radiotherapy for prostate cancer
Allan 'Ben' Smith, Orlando Rincones, Pascal Mancuso, et al.
Current Oncology (Toronto, Ont.)
|
February 24, 2023
Encouraging Patients to Ask Questions: Development and Pilot Testing of a Question Prompt List for Patients Undergoing a Biopsy for Suspected Prostate Cancer
Orlando Rincones, Allan 'Ben' Smith, Peter Chong, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
December 13, 2019
High negative predictive value of 68Ga PSMA PET-CT for local lymph node metastases in high risk primary prostate cancer with histopathological correlation
Labib Ataur Rahman, Damacent Rutagengwa, Peter Lin, et al.
The Lancet. Oncology
|
February 29, 2024
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial
Shankar Siva, Mathias Bressel, Mark Sidhom, et al.
The Lancet. Oncology
|
May 17, 2026
Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study
Shankar Siva, David Pryor, Jarad Martin, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Urology Case Reports
|
April 6, 2017
A Case Report of Priapism With Unusual Presentation and Clinical Course
Wenjie Zhong, Hamesh Jina, Prem Rathore, et al.
Patient Education and Counseling
|
February 27, 2019
Robot or radiation? A qualitative study of the decision support needs of men with localised prostate cancer choosing between robotic prostatectomy and radiotherapy treatment
Allan 'Ben' Smith, Orlando Rincones, Mark Sidhom, et al.
BMJ Open
|
November 6, 2017
Prostatectomy versus radiotherapy for early-stage prostate cancer (PREPaRE) study: protocol for a mixed-methods study of treatment decision-making in men with localised prostate cancer
Allan Ben Smith, Pascal Mancuso, Mark Sidhom, et al.
Urologic Oncology
|
June 12, 2021
Low conflict and high satisfaction: Decisional outcomes after attending a combined clinic to choose between robotic prostatectomy and radiotherapy for prostate cancer
Allan 'Ben' Smith, Orlando Rincones, Pascal Mancuso, et al.
Current Oncology (Toronto, Ont.)
|
February 24, 2023
Encouraging Patients to Ask Questions: Development and Pilot Testing of a Question Prompt List for Patients Undergoing a Biopsy for Suspected Prostate Cancer
Orlando Rincones, Allan 'Ben' Smith, Peter Chong, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
December 13, 2019
High negative predictive value of 68Ga PSMA PET-CT for local lymph node metastases in high risk primary prostate cancer with histopathological correlation
Labib Ataur Rahman, Damacent Rutagengwa, Peter Lin, et al.
The Lancet. Oncology
|
February 29, 2024
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial
Shankar Siva, Mathias Bressel, Mark Sidhom, et al.
The Lancet. Oncology
|
May 17, 2026
Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study
Shankar Siva, David Pryor, Jarad Martin, et al.
Page
of 2